Mouse Anti-Human CD59 Monoclonal Antibody (CTJS-331)(Cat#: CTA-259)
This product is an unconjugated anti-Human CD59 Monoclonal antibody (CTJS-331) generated from the Mouse. The antibody can be used for FC; IHC; ICC.
Summary
Related Products & Services
Specifications
| Clonality |
Monoclonal |
| Clone |
CTJS-331 |
| Host Animal |
Mouse |
| Isotype |
IgM Kappa |
| Immunogen |
Stimulated human leukocytes |
| Species Reactivity |
Human |
| Applications |
FC; IHC; ICC |
| Application Notes |
FC: 0.5 - 1 ug/10^6 cells
IF: 0.5 - 1.0 µg/mL
The optimal working dilutions should be determined by the end user. |
| Specificity |
This antibody reacts with Human CD59. |
| Purity |
≥95% as determined by SDS-PAGE |
| Format |
Liquid |
| Size |
20; 100 µg |
| Storage |
4°C |
| Type |
Primary Antibody |
Target
| Target Name |
CD59 |
| Alternative Names |
T cell-activating protein; 16.3A5; 1F5 antigen; 1F5; 20 kDa homologous restriction factor; CD59 antigen p18-20 (antigen identified by; monoclonal antibodies 16.3A5; EJ16; CD59 antigen; CD59 antigen; complement regulatory protein; CD59 glycoprotein; CD59 molecule; complement regulatory protein; CD59; EJ16; EJ30; EJ30; EL32 and G344); EL32; FLJ38134; FLJ92039; G344; HRF20; HRF-20; human leukocyte antigen MIC11; Ly-6-like protein; lymphocytic antigen CD59/MEM43; MACIF; MAC-inhibitory protein; MAC-IP; MEM43 antigen; MEM43; membrane attack complex (MAC) inhibition factor; Membrane attack complex inhibition factor; Membrane inhibitor of reactive lysis; MGC2354; MIC11; MIC11MSK21; MIN1; MIN2; MIN3; MIRL; p18-20; Protectin; surface anitgen recognized by monoclonal 16.3A5 |
| Gene ID |
966 |
| UniProt ID |
P13987 |
Information
| Introduction |
CD59 glycoprotein, also known as MAC-inhibitory protein (MAC-IP), membrane inhibitor of reactive lysis (MIRL), or protectin, is a protein that in humans is encoded by the CD59 gene. It belongs to the LY6/uPAR/alpha-neurotoxin protein family. CD59 attaches to host cells via a glycophosphatidylinositol (GPI) anchor. When complement activation leads to deposition of C5b678 on host cells, CD59 can prevent C9 from polymerizing and forming the complement membrane attack complex. It may also signal the cell to perform active measures such as endocytosis of the CD59-CD9 complex. Mutations affecting GPI that reduce expression of CD59 and decay-accelerating factor on red blood cells result in paroxysmal nocturnal hemoglobinuria. Viruses such as HIV, human cytomegalovirus and vaccinia incorporate host cell CD59 into their own viral envelope to prevent lysis by complement. |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
